Search the Newsreel

Ardent Health, Inc. (ARDT) Stock Price, News, Quote & History

This article provides a detailed financial overview of Ardent Health, Inc. (ARDT), including its current stock price, historical performance, key financial metrics, and analyst recommendations. It highlights the company's business operations in medical care facilities and its recent earnings trends, alongside comparisons with similar …

Ardent Health Partners Inc (ARDT) Financial Health: Profitability & Balance Sheet Analysis

The article provides a financial health analysis of Ardent Health Partners Inc (ARDT), noting its current score of 7.05, placing it 55th out of 75 in the Healthcare Providers & Services industry. The company is described as stable with high operating efficiency, reporting a …

Ardent Health surpasses 1 million patient encounters supported by ambient AI

Ardent Health announced that its physicians and advanced practice providers have surpassed 1 million patient encounters utilizing Ambience Healthcare's ambient AI platform. This achievement highlights Ardent's success in integrating ambient AI into clinical workflows, significantly reducing documentation burden and improving patient care. Clinicians using …

ARDT|Ardent Health Partners Inc|Price:10.400|Chg%:+0.030

Ardent Health Partners Inc (ARDT) is trading at $10.930, up 4.89%. The company has healthy fundamentals, high growth potential, and is considered fairly valued by analysts who rate it a "Buy" with a target price of $12.15. Ardent Health operates 30 acute care hospitals …

Ardent Health reaches 1 million AI-assisted patient encounters

Ardent Health Services has achieved 1 million AI-assisted patient encounters using Ambience Healthcare’s ambient AI documentation platform. The technology, deployed since September 2025, helps providers like family medicine physician Jennie Zheng save over three hours per week in documentation time, allowing them to focus …

Ardent Health's Q2 Results Call Replay Runs Through Aug. 19

Ardent Health (NYSE: ARDT) announced its second-quarter 2026 financial results would be released on August 4, 2026, with a conference call scheduled for August 5, 2026, at 10 a.m. ET to discuss the results. A replay of the teleconference will be available until August …

Wockhardt Ltd shares plunge over 8% amid profit booking pressure after a 50% rally

Wockhardt's (NSE:WOCKPHARMA) Strong Earnings Are Of Good Quality

Wockhardt Share Price Target 2026: Analyst Forecast, Growth Catalysts and Key Risks

Wockhardt Swings to Profit as FY26 Revenue and EBITDA Surge

Wockhardt shares surge over 12% to 9-month high as company swings to profit in Q4

Wockhardt shares soar over 12% as loss turns to profit in Q4, EBITDA surges 147% YoY; key details to know

While individual investors own 34% of Wockhardt Limited (NSE:WOCKPHARMA), private companies are its largest shareholders with 50% ownership

Is Wockhardt (NSE:WOCKPHARMA) Using Too Much Debt?

Wockhardt Limited's (NSE:WOCKPHARMA) Price Is Out Of Tune With Revenues

Wockhardt shares advance 12% as net loss flips to profit of ₹78 crore in Q2

Wockhardt Reports Profit in Q2FY26, Exits US Generic Pharma Business